𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Placebo-controlled comparative study of the anxiolytic activity and of the pharmacokinetics of oral and sublingual lorazepam in generalized anxiety

✍ Scribed by J. Spénard; Dr. G. Caillé; M. VÉZina; L. Larivière; F. Trudel; J. Ouellette; C. De Montigny

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
437 KB
Volume
9
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ritanserin in the treatment of generaliz
Ritanserin in the treatment of generalized anxiety disorders: A placebo-controlled trial
✍ E. A. Pangalila-Ratu Langi; A. A. I. Jansen 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

In a double-blind trial, 22 patients treated with 5 mg b.i.d. of the selective serotonin-S2 antagonist ritanserin for 4 weeks were compared with 26 patients treated with placebo for generalized anxiety disorder (DSM 111: 300.02). Symptoms were assessed using the Hamilton Anxiety Rating Scale (HARS)

Escitalopram in the treatment of general
Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study
✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Efficacy of etifoxine compared to loraze
Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice
✍ N. Nguyen; E. Fakra; V. Pradel; E. Jouve; C. Alquier; M-E. Le Guern; J. Micallef 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

## Abstract Adjustment Disorders With Anxiety (ADWA) account for almost 10% of psychologically motivated consultations in primary care. The aim of this double‐blind randomised parallel group study was to compare (non‐inferiority test) the efficacies of etifoxine, a non‐benzodiazepine anxiolytic dru